MEDMARK TREATMENT CENTERS - CHERRY HILL
NPI 1093071920
Clinic/Center - Methadone in Baltimore, MD

Active since April 04, 2012CLIA 21D2034079 · Waiver
1801 CHERRY HILL RD, BALTIMORE, MD 21230(410) 354-2800 Get Directions Write a Review

NPPES record last updated: July 29, 2024. Verified against the NPPES registry weekly; last sync: July 26, 2026.

Record update history: Jul 29, 2024, Jan 19, 2023, Apr 20, 2022 and 5 more (8 updates tracked since 2017).

About Medmark Treatment Centers - Cherry Hill NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

MEDMARK TREATMENT CENTERS - CHERRY HILL (NPI 1093071920) is a healthcare organization registered as a methadone in Baltimore, Maryland and active in the NPI registry since April 2012. The organization holds a CLIA Waiver certificate valid through December 14, 2027 and lists Bruce Jarvie, Vp, Treasurer, as its authorized official.

NPPES Registry Identity

NPI1093071920
Entity TypeOrganization
Primary Taxonomy261QM2800X
Legal Business NameGLASS HEALTH PROGRAMS, INC.
Location Address1801 CHERRY HILL RDBaltimore, MD 21230
Mailing Address1720 Lakepointe Dr Ste 117Lewisville, TX 75057-6425 · (214) 379-3300 · Fax (214) 853-9018
Organization SubpartYesParent: Glass Health Programs, Inc
Authorized OfficialBruce JarvieVp, Treasurer · (214) 379-3300
Enumeration DateApril 4, 2012
Last NPPES UpdateJuly 29, 20248 updates tracked since enumeration
NPPES CertifiedJuly 29, 2024
NPI 1093071920 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyClinic/Center · MethadoneAmbulatory Health Care Facilities
Taxonomy Code261QM2800X
Licenses Licensed in MD · 904748 Licensed in MD · 903985
Definition

An entity, facility, or distinct part of a facility providing diagnostic, and replacement maintenance treatment services related to individuals with drug addiction.

Also ListedClinic/Center · Rehabilitation, Substance Use DisorderTaxonomy 261QR0405X · License 904748 (MD)
1801 CHERRY HILL RD, Baltimore, MD 21230

Other Names 1

Doing Business AsMedmark Treatment Centers - Cherry Hill

Other Identifiers 1

Medicaid03919104MD

CLIA Laboratory Certificates CMS CLIA

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Waiver 21D2034079

Glass Health Programs Inc Dba Mtc Cherry Hill · Baltimore, MD
Active · expires Dec 14, 2027
CLIA Number21D2034079
Laboratory TypeNarcotics Treatment Prog
Certificate Effective DateDecember 15, 2025
Certificate Expiration DateDecember 14, 2027
Laboratory DirectorYashica Ruffin
Laboratory Phone(214) 379-3318
Laboratory LocationGlass Health Programs Inc Dba Mtc Cherry Hill1801 Cherry Hill Road, Baltimore, MD 21230
CLIA data matches this NPI record on: Address Name
This certificate is issued to a laboratory to perform only waived tests.

Areas of Expertise CMS Part B claims 4

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm G2067
Medication Assisted Treatment (MAT) with methadone is a comprehensive approach to manage opioid addiction. It includes weekly methadone dispensing, substance use counseling, individual and group therapy sessions, and toxicology tests as needed, all provided by a Medicare-enrolled opioid treatment program.
1,173 services48 patients
Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure G2078
This service provides an additional 7-day supply of methadone, a medication used to treat opioid addiction, for patients to take at home. It's provided by a Medicare-enrolled opioid treatment program. This service is billed separately from the main treatment procedure.
762 services30 patients
Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for G2077
Periodic assessment is a routine check-up by trained professionals to determine the best mix of services and treatments for your health needs. This is typically provided by a Medicare-enrolled opioid treatment program. It's listed separately in addition to your main treatment code. This ensures you receive the most suitable care for your situation.
95 services39 patients
Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) G2074
Medication Assisted Treatment is a comprehensive program for managing substance use. It includes counseling (both individual and group), along with regular toxicology testing if required. This service is provided by a Medicare-enrolled opioid treatment program.
90 services21 patients

Other Providers at the Same Location NPPES 13

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Counselor
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Counselor (Addiction (Substance Use Disorder))
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Counselor (Addiction (Substance Use Disorder))
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Counselor (Addiction (Substance Use Disorder))
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Counselor (Addiction (Substance Use Disorder))
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Counselor (Addiction (Substance Use Disorder))
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Counselor (Addiction (Substance Use Disorder))
1801 CHERRY HILL RD
BALTIMORE, MD 21230
Clinic/Center (Rehabilitation, Substance Use Disorder)
1801 CHERRY HILL RD
BALTIMORE, MD 21230

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Glass Health Programs, Inc.'s NPI number?

The NPI number for Glass Health Programs, Inc. is 1093071920. It was assigned to this organization in the NPPES registry on April 4, 2012. The provider is doing business as Medmark Treatment Centers - Cherry Hill.

Where is Glass Health Programs, Inc. located?

Glass Health Programs, Inc. is located at 1801 Cherry Hill Rd, Baltimore, MD 21230. The listed phone number is (410) 354-2800.

What is Glass Health Programs, Inc.'s specialty?

The primary specialty registered for this NPI is Clinic/Center, specializing in Methadone, with taxonomy code 261QM2800X.

Does Glass Health Programs, Inc. hold a CLIA laboratory certificate?

Yes. A Certificate of Waiver (number 21D2034079) is associated with this NPI, valid through December 14, 2027. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.

When was this NPI record last updated?

The NPPES record for Glass Health Programs, Inc. was last updated on July 29, 2024. NPI Profile syncs with the weekly NPPES data releases published by CMS.